Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
106 participants
INTERVENTIONAL
2024-11-06
2026-11-07
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Deep Neuromuscular Blockade on Requirement of Intravenous Anesthetic Agent
NCT03890406
Depth of Neuromuscular Blockade and the Perioperative Conditions in Laparoscopic Surgery in Pediatric Population
NCT02546843
Effectiveness of Deep Versus Moderate Neuromuscular Blockade
NCT03266419
The Laparotomy Study
NCT02140593
Compare of Surgical Condition and Complications With Moderate and Deep NM Block
NCT02601508
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
moderate neuromuscular blockade
rocuronium 0.2 mg/kg/hr continuous infusion
To maintain Train-of-four count 1 to 3 during surgery: Administration of continuous infusion of rocuronium at a rate of 0.2 mg/kg/hr to achieve and sustain moderate neuromuscular blockade.
deep neuromuscular blockade
rocuronium 0.6 mg/kg/hr continuous infusion
To maintain Train-of-four count 0 during surgery: Administration of continuous infusion of rocuronium at a rate of 0.6 mg/kg/hr to achieve and sustain deep neuromuscular blockade.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
rocuronium 0.2 mg/kg/hr continuous infusion
To maintain Train-of-four count 1 to 3 during surgery: Administration of continuous infusion of rocuronium at a rate of 0.2 mg/kg/hr to achieve and sustain moderate neuromuscular blockade.
rocuronium 0.6 mg/kg/hr continuous infusion
To maintain Train-of-four count 0 during surgery: Administration of continuous infusion of rocuronium at a rate of 0.6 mg/kg/hr to achieve and sustain deep neuromuscular blockade.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists (ASA) Physical Status Classification I, II, or III.
Exclusion Criteria
* Patients with chronic pain or currently taking analgesics for chronic pain.
* Known hypersensitivity to general anesthetic agents or analgesics.
* Patients with underlying cardiovascular disease.
* Patients with neuromuscular disorders.
* Any other condition that, in the investigator's judgment, would make the patient unsuitable for participation in the study.
2 Months
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ji-Hyun Lee
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
SNUCH
Seoul, Seoul, South Korea
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2410-015-1575
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.